BIOCRYST PHARMACEUTICALS INC (BCRX)
BioCryst Presents New Clinical Data and Real-World Evidence Demonstrating Impact of HAE Portfolio at the 2026 European Academy of Allergy and Clinical Immunology Annual Meeting
BioCryst Presents New Clinical Data and Real-World Evidence Demonstrating Impact of HAE Portfolio at the 2026 European Academy of Allergy and Clinical Immunology Annual Meeting
MBX Biosciences Announces One-Year Data Demonstrating Sustained Benefit of Once-Weekly Canvuparatide as a Potential PTH Replacement Therapy in Chronic Hypoparathyroidism
QXO Announces Early Tender Results of Cash Tender Offers and Consent Solicitations for Any and All of TopBuild Corp.’s 4.125% Senior Notes due 2032 and 5.625% Senior Notes due 2034 and Receipt of Requisite Consents
Roots Reports First Quarter Fiscal 2026 Results & Business Update
Mandatory Cash Dividend/ Distribution:
Share Buy Back - Daily Share Buy-Back Notice: S$2Bn Value Realisation Share Buy-back Programme
General Announcement: Press Release-Annica Secures Commercial Project; Proposed Expansion of Existing Framework Agreement
Mandatory Warrant Exercise :
Mandatory Warrant Exercise :
Mandatory Warrant Exercise :